A
$ Value
$0
Shares
30,000
Price
$0
Filed
Aug 11
Insider
Name
Klein Uwe
Title
SVP, Biological Sciences
CIK
0002040350
Roles
Officer
Transaction Details
Transaction Date
2025-08-07
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
30,000
Footnotes
1/48th of the shares subject to such option shall vest and become exercisable in substantially equal monthly installments on each monthly anniversary of August 1, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date.
Filing Info
Klein Uwe's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-06 | SEPN | A | $0 |
| 2025-08-18 | SEPN | M | $29K |
| 2025-08-18 | SEPN | M | $14K |
| 2025-08-18 | SEPN | M | $52K |
| 2025-08-18 | SEPN | M | $0 |
| 2025-08-18 | SEPN | M | $0 |
| 2025-08-18 | SEPN | M | $0 |
| 2025-08-07 | SEPN | A | $0 |
Other Insiders at SEPN (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Labrucherie Gil M
Chief Financial Officer
|
— | — | 2026-02-06 |
|
Bhatt Elizabeth
President and COO
|
— | $97K | 2026-04-15 |
|
Wilson Mark Andrew
Chief Legal Officer
|
— | — | 2026-02-06 |
|
Kim Jae B.
Chief Medical Officer
|
— | — | 2026-02-06 |
|
Long Daniel D.
SVP, Drug Discovery
|
— | — | 2026-02-06 |
|
Klein Uwe
SVP, Biological Sciences
|
— | — | 2026-02-06 |
|
Shaikhly Samira
Chief People Officer
|
— | — | 2026-02-06 |
|
Finer Jeffrey
Chief Executive Officer
|
— | — | 2026-02-06 |